Xiaolin Tang

Person

Old Tappan, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Process for reducing subvisible particles in a pharmaceutical formu...
- Patent number 12,070,502
- Issue date Aug 27, 2024
- REGENERON PHARMACEUTICALS, INC.
- Hanne Bak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Target residual moisture content for lyophilized drug product
- Patent number 12,066,246
- Issue date Aug 20, 2024
- REGENERON PHARMACEUTICALS, INC.
- Xiaolin Tang
- F26 - DRYING
Information Patent Grant
Methods of reducing particle formation and compositions formed thereby
- Patent number 12,042,538
- Issue date Jul 23, 2024
- REGENERON PHARMACEUTICALS, INC.
- Mayank Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-interleukin-4 receptor (IL-...
- Patent number 11,926,670
- Issue date Mar 12, 2024
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Target residual moisture content for lyophilized drug product
- Patent number 11,713,922
- Issue date Aug 1, 2023
- Regeneran Pharmaceuticals, Inc.
- Xiaolin Tang
- F26 - DRYING
Information Patent Grant
Target residual moisture content for lyophilized drug product
- Patent number 11,525,629
- Issue date Dec 13, 2022
- REGENERON PHARMACEUTICALS, INC.
- Xiaolin Tang
- F26 - DRYING
Information Patent Grant
Room temperature stable lyophilized protein
- Patent number 11,351,256
- Issue date Jun 7, 2022
- REGENERON PHARMACEUTICALS, INC.
- Xiaolin Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Room temperature stable lyophilized protein
- Patent number 11,241,498
- Issue date Feb 8, 2022
- Regeneran Pharmaceuticals, Inc.
- Xiaolin Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-interleukin-4 receptor (IL-...
- Patent number 11,059,896
- Issue date Jul 13, 2021
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-interleukin-4 receptor (IL-...
- Patent number 10,435,473
- Issue date Oct 8, 2019
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for reducing subvisible particles in a pharmaceutical formu...
- Patent number 10,342,876
- Issue date Jul 9, 2019
- REGENERON PHARMACEUTICALS, INC.
- Hanne Bak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-interleukin-4 receptor (IL-...
- Patent number 9,238,692
- Issue date Jan 19, 2016
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-interleukin-4 receptor (IL-...
- Patent number 8,945,559
- Issue date Feb 3, 2015
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PROCESS FOR REDUCING SUBVISIBLE PARTICLES IN A PHARMACEUTICAL FORMU...
- Publication number 20240415969
- Publication date Dec 19, 2024
- Regeneron Pharmaceuticals, Inc.
- Hanne BAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT
- Publication number 20240393045
- Publication date Nov 28, 2024
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- F26 - DRYING
Information Patent Application
MULTIDOSE ANTIBODY DRUG PRODUCTS USING PHENOL OR BENZYL ALCOHOL
- Publication number 20240366471
- Publication date Nov 7, 2024
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...
- Publication number 20240360230
- Publication date Oct 31, 2024
- Regeneron Pharmaceuticals, Inc.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR SELECTING EXCIPIENTS AND FOR PREPARING HIGH CONCENTRATI...
- Publication number 20240360591
- Publication date Oct 31, 2024
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
ANTI-FEL D1 ANTIBODY FORMULATIONS
- Publication number 20240352103
- Publication date Oct 24, 2024
- Regeneron Pharmaceuticals, Inc.
- Hunter Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREBY
- Publication number 20240335534
- Publication date Oct 10, 2024
- Regeneron Pharmaceuticals, Inc.
- Mayank PATEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR REDUCING LIPASE ACTIVITY
- Publication number 20240199688
- Publication date Jun 20, 2024
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C5 ANTIBODY/C5 IRNA CO-FORMULATIONS AND COMBINATION THERAPIES
- Publication number 20240175027
- Publication date May 30, 2024
- Regeneron Pharmaceuticals, Inc.
- Mary Kleppe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Anti-Interleukin-4 Receptor (IL-4R) Antibody Formulations
- Publication number 20240024472
- Publication date Jan 25, 2024
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MANUFACTURING PROCESS FOR HIGH TITER ANTIBODY
- Publication number 20240010737
- Publication date Jan 11, 2024
- Regeneron Pharmaceuticals, Inc.
- John Mattila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT
- Publication number 20230358470
- Publication date Nov 9, 2023
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- F26 - DRYING
Information Patent Application
MANUFACTURING PROCESS FOR HIGH TITER ANTIBODY
- Publication number 20230348532
- Publication date Nov 2, 2023
- Regeneron Pharmaceuticals, Inc.
- John Mattila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MANUFACTURING PROCESS FOR HIGH TITER ANTIBODY
- Publication number 20230331776
- Publication date Oct 19, 2023
- Regeneron Pharmaceuticals, Inc.
- John Mattila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CELL CULTURE METHODS FOR ANTIBODY PRODUCTION
- Publication number 20230332201
- Publication date Oct 19, 2023
- Regeneron Pharmaceuticals, Inc.
- John Mattila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOREACTOR FOR ANTIBODY PRODUCTION
- Publication number 20230332084
- Publication date Oct 19, 2023
- Regeneron Pharmaceuticals, Inc.
- John Mattila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELL CULTURE METHODS FOR ANTIBODY PRODUCTION
- Publication number 20230287043
- Publication date Sep 14, 2023
- Regeneron Pharmaceuticals, Inc.
- John Mattila
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT
- Publication number 20230077563
- Publication date Mar 16, 2023
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ROOM TEMPERATURE STABLE LYOPHILIZED PROTEIN
- Publication number 20220257763
- Publication date Aug 18, 2022
- Regeneron Pharmaceuticals, Inc.
- Xiaolin TANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-CTLA-4 Antibodies
- Publication number 20220031843
- Publication date Feb 3, 2022
- Regeneron Pharmaceuticals, Inc.
- Yuan CHENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...
- Publication number 20210403581
- Publication date Dec 30, 2021
- Regeneron Pharmaceuticals, Inc.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT
- Publication number 20210239396
- Publication date Aug 5, 2021
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-CD20 x Anti-CD3 Bispecific...
- Publication number 20210206870
- Publication date Jul 8, 2021
- Regeneron Pharmaceuticals, Inc.
- Yuan Cheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH CONCENTRATION ANTI-C5 FORMULATIONS
- Publication number 20210046182
- Publication date Feb 18, 2021
- Regeneron Pharmaceuticals, Inc.
- Mary Kleppe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ROOM TEMPERATURE STABLE LYOPHILIZED PROTEIN
- Publication number 20200046834
- Publication date Feb 13, 2020
- Regeneron Pharmaceuticals, Inc.
- Xiaolin Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...
- Publication number 20190367624
- Publication date Dec 5, 2019
- Regeneron Pharmaceuticals, Inc.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR REDUCING SUBVISIBLE PARTICLES IN A PHARMACEUTICAL FORMU...
- Publication number 20190231877
- Publication date Aug 1, 2019
- Hanne BAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREBY
- Publication number 20190083618
- Publication date Mar 21, 2019
- Regeneron Pharmaceuticals, Inc.
- Mayank PATEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Antibody Compositions and Methods of Producing Same
- Publication number 20190021952
- Publication date Jan 24, 2019
- Regeneron Pharmaceuticals, Inc.
- Xiaolin TANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Room Temperature Stable Lyophilized Protein
- Publication number 20180099049
- Publication date Apr 12, 2018
- Regeneron Pharmaceuticals, Inc.
- Xiaolin TANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Xiaolin Tang

Person

Patents Grantslast 30 patents

Process for reducing subvisible particles in a pharmaceutical formu...

Target residual moisture content for lyophilized drug product

Methods of reducing particle formation and compositions formed thereby

Stabilized formulations containing anti-interleukin-4 receptor (IL-...

Target residual moisture content for lyophilized drug product

Target residual moisture content for lyophilized drug product

Room temperature stable lyophilized protein

Room temperature stable lyophilized protein

Stabilized formulations containing anti-interleukin-4 receptor (IL-...

Stabilized formulations containing anti-interleukin-4 receptor (IL-...

Process for reducing subvisible particles in a pharmaceutical formu...

Stabilized formulations containing anti-interleukin-4 receptor (IL-...

Stabilized formulations containing anti-interleukin-4 receptor (IL-...

Patents Applicationslast 30 patents

PROCESS FOR REDUCING SUBVISIBLE PARTICLES IN A PHARMACEUTICAL FORMU...

TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT

MULTIDOSE ANTIBODY DRUG PRODUCTS USING PHENOL OR BENZYL ALCOHOL

Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...

METHODS FOR SELECTING EXCIPIENTS AND FOR PREPARING HIGH CONCENTRATI...

ANTI-FEL D1 ANTIBODY FORMULATIONS

METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREBY

METHODS FOR REDUCING LIPASE ACTIVITY

ANTI-C5 ANTIBODY/C5 IRNA CO-FORMULATIONS AND COMBINATION THERAPIES

Anti-Interleukin-4 Receptor (IL-4R) Antibody Formulations

MANUFACTURING PROCESS FOR HIGH TITER ANTIBODY

TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT

MANUFACTURING PROCESS FOR HIGH TITER ANTIBODY

MANUFACTURING PROCESS FOR HIGH TITER ANTIBODY

CELL CULTURE METHODS FOR ANTIBODY PRODUCTION

BIOREACTOR FOR ANTIBODY PRODUCTION

CELL CULTURE METHODS FOR ANTIBODY PRODUCTION

TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT

ROOM TEMPERATURE STABLE LYOPHILIZED PROTEIN

Stabilized Formulations Containing Anti-CTLA-4 Antibodies

Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...

TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT

Stabilized Formulations Containing Anti-CD20 x Anti-CD3 Bispecific...

HIGH CONCENTRATION ANTI-C5 FORMULATIONS

ROOM TEMPERATURE STABLE LYOPHILIZED PROTEIN

Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...

PROCESS FOR REDUCING SUBVISIBLE PARTICLES IN A PHARMACEUTICAL FORMU...

METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREBY

Stabilized Antibody Compositions and Methods of Producing Same

Room Temperature Stable Lyophilized Protein